Evidence map›Paper›PMID 35928441›Full record

ArticleFrontiers in genetics2022

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma.

Liang Sun, Shian Yu, Cairong Dong, Zhengyi Wu, He Huang, Zhendong Chen, Zhipeng Wu, Xiangbao Yin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liang SunDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Shian YuDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Cairong DongDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhengyi WuDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
He HuangDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhendong ChenDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhipeng WuDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xiangbao YinDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Second Affiliated Hospital of Nanchang University · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformatics analysisficolin familyhepatocellular carcinomaimmunotherapyprognosis

Identifiers

PMID35928441
PMCPMC9343789
OpenAlexW4286217211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.